ARTICLE | Company News
Atrix receives Canadian marketing approval
July 6, 2000 7:00 AM UTC
ATRX received marketing approval in Canada for its Atridox doxycycline antibiotic using the Atrigel delivery system to treat periodontal disease. Block Drug Co. (BLOCA) will market the product in Cana...